中药治疗对比剂肾病的最新进展。 - Suppr

Recent advances in Chinese medicine for contrast-induced nephropathy.

作者信息

Gong Xue-Zhong

机构信息

Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.

出版信息

Chin J Integr Med. 2018 Jan;24(1):6-9. doi: 10.1007/s11655-017-2906-x. Epub 2017 Oct 6.

DOI:10.1007/s11655-017-2906-x

PMID:28986810

Abstract

摘要

相似文献

Recent advances in Chinese medicine for contrast-induced nephropathy.

Chin J Integr Med. 2018 Jan;24(1):6-9. doi: 10.1007/s11655-017-2906-x. Epub 2017 Oct 6.

Contrast-induced nephropathy-time for Western medicine and Chinese medicine to team up.

Chin J Integr Med. 2018 Jan;24(1):3-5. doi: 10.1007/s11655-017-2905-y. Epub 2017 Oct 6.

Water for contrast-induced nephropathy? A thirst for knowledge.

J Invasive Cardiol. 2003 Dec;15(12):703-5.

Selecting appropriate contrast media for preventing contrast-induced nephropathy.

Acta Radiol. 2008 Sep;49(7):787; author reply 788-9.

Contrast-induced nephropathy: prevention and management of high-risk patients.

Indian Heart J. 2008 Nov-Dec;60(6):524-31.

[Contrast-media-induced nephrotoxicity].

Dtsch Med Wochenschr. 2005 Oct 21;130(42):2391-6. doi: 10.1055/s-2005-918582.

The editor's roundtable: contrast-induced nephropathy.

Am J Cardiol. 2007 Aug 1;100(3):544-51. doi: 10.1016/j.amjcard.2007.05.021. Epub 2007 Jun 4.

Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives.

Nephrol Dial Transplant. 1998 Nov;13(11):2976-7.

N-acetylcysteine and contrast-induced nephropathy.

N Engl J Med. 2006 Oct 5;355(14):1498; author reply 1499-500.

Contrast-induced nephropathy and the vascular patient.

Angiology. 2010 Nov;61(8):721-3. doi: 10.1177/0003319710379110. Epub 2010 Aug 3.

引用本文的文献

Berberine alleviates contrast-induced nephropathy by activating Akt/Foxo3a/Nrf2 signalling pathway.

J Cell Mol Med. 2024 Jan;28(1):e18016. doi: 10.1111/jcmm.18016. Epub 2023 Nov 1.

Nephroprotective mechanisms of Rhizoma Chuanxiong and Radix et Rhizoma Rhei against acute renal injury and renal fibrosis based on network pharmacology and experimental validation.

Front Pharmacol. 2023 May 9;14:1154743. doi: 10.3389/fphar.2023.1154743. eCollection 2023.

Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial.

Front Pharmacol. 2022 Oct 3;13:969107. doi: 10.3389/fphar.2022.969107. eCollection 2022.

Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial.

Evid Based Complement Alternat Med. 2022 Mar 15;2022:1099642. doi: 10.1155/2022/1099642. eCollection 2022.

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis.

Front Pharmacol. 2022 Jan 25;13:820071. doi: 10.3389/fphar.2022.820071. eCollection 2022.

本文引用的文献

Protective Effects of Salvianolate on Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention: A Prospective Multicenter Randomized Controlled Trial.

Cardiology. 2017;138(3):169-178. doi: 10.1159/000475746. Epub 2017 Jul 27.

Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.

Front Med (Lausanne). 2017 May 26;4:64. doi: 10.3389/fmed.2017.00064. eCollection 2017.

Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention.

Clin Cardiol. 2017 Sep;40(9):719-725. doi: 10.1002/clc.22722. Epub 2017 May 19.

Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats.

Oxid Med Cell Longev. 2016;2016:8715185. doi: 10.1155/2016/8715185. Epub 2016 Dec 26.

Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.

BMC Nephrol. 2014 Jan 6;15:2. doi: 10.1186/1471-2369-15-2.

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.

Insights Imaging. 2013 Dec;4(6):811-20. doi: 10.1007/s13244-013-0291-3. Epub 2013 Oct 3.

Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways.

Am J Nephrol. 2013;37(3):199-207. doi: 10.1159/000347033. Epub 2013 Feb 26.

Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.

Singapore Med J. 2012 Mar;53(3):164-9.

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Eur Radiol. 2011 Dec;21(12):2527-41. doi: 10.1007/s00330-011-2225-0. Epub 2011 Aug 25.

N-acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling.

Am J Nephrol. 2010;31(2):178-88. doi: 10.1159/000268161. Epub 2009 Dec 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Recent advances in Chinese medicine for contrast-induced nephropathy.

作者信息

Gong Xue-Zhong

机构信息

Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.

出版信息

Chin J Integr Med. 2018 Jan;24(1):6-9. doi: 10.1007/s11655-017-2906-x. Epub 2017 Oct 6.

DOI:10.1007/s11655-017-2906-x

PMID:28986810

Abstract

摘要

相似文献

Recent advances in Chinese medicine for contrast-induced nephropathy.

Chin J Integr Med. 2018 Jan;24(1):6-9. doi: 10.1007/s11655-017-2906-x. Epub 2017 Oct 6.

Contrast-induced nephropathy-time for Western medicine and Chinese medicine to team up.

Chin J Integr Med. 2018 Jan;24(1):3-5. doi: 10.1007/s11655-017-2905-y. Epub 2017 Oct 6.

Water for contrast-induced nephropathy? A thirst for knowledge.

J Invasive Cardiol. 2003 Dec;15(12):703-5.

Selecting appropriate contrast media for preventing contrast-induced nephropathy.

Acta Radiol. 2008 Sep;49(7):787; author reply 788-9.

Contrast-induced nephropathy: prevention and management of high-risk patients.

Indian Heart J. 2008 Nov-Dec;60(6):524-31.

[Contrast-media-induced nephrotoxicity].

Dtsch Med Wochenschr. 2005 Oct 21;130(42):2391-6. doi: 10.1055/s-2005-918582.

The editor's roundtable: contrast-induced nephropathy.

Am J Cardiol. 2007 Aug 1;100(3):544-51. doi: 10.1016/j.amjcard.2007.05.021. Epub 2007 Jun 4.

Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives.

Nephrol Dial Transplant. 1998 Nov;13(11):2976-7.

N-acetylcysteine and contrast-induced nephropathy.

N Engl J Med. 2006 Oct 5;355(14):1498; author reply 1499-500.

Contrast-induced nephropathy and the vascular patient.

Angiology. 2010 Nov;61(8):721-3. doi: 10.1177/0003319710379110. Epub 2010 Aug 3.

引用本文的文献

Berberine alleviates contrast-induced nephropathy by activating Akt/Foxo3a/Nrf2 signalling pathway.

J Cell Mol Med. 2024 Jan;28(1):e18016. doi: 10.1111/jcmm.18016. Epub 2023 Nov 1.

Nephroprotective mechanisms of Rhizoma Chuanxiong and Radix et Rhizoma Rhei against acute renal injury and renal fibrosis based on network pharmacology and experimental validation.

Front Pharmacol. 2023 May 9;14:1154743. doi: 10.3389/fphar.2023.1154743. eCollection 2023.

Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial.

Front Pharmacol. 2022 Oct 3;13:969107. doi: 10.3389/fphar.2022.969107. eCollection 2022.

Evid Based Complement Alternat Med. 2022 Mar 15;2022:1099642. doi: 10.1155/2022/1099642. eCollection 2022.

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis.

Front Pharmacol. 2022 Jan 25;13:820071. doi: 10.3389/fphar.2022.820071. eCollection 2022.

本文引用的文献

Protective Effects of Salvianolate on Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention: A Prospective Multicenter Randomized Controlled Trial.

Cardiology. 2017;138(3):169-178. doi: 10.1159/000475746. Epub 2017 Jul 27.

Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.

Front Med (Lausanne). 2017 May 26;4:64. doi: 10.3389/fmed.2017.00064. eCollection 2017.

Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention.

Clin Cardiol. 2017 Sep;40(9):719-725. doi: 10.1002/clc.22722. Epub 2017 May 19.

Oxid Med Cell Longev. 2016;2016:8715185. doi: 10.1155/2016/8715185. Epub 2016 Dec 26.

Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.

BMC Nephrol. 2014 Jan 6;15:2. doi: 10.1186/1471-2369-15-2.

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.

Insights Imaging. 2013 Dec;4(6):811-20. doi: 10.1007/s13244-013-0291-3. Epub 2013 Oct 3.

Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways.

Am J Nephrol. 2013;37(3):199-207. doi: 10.1159/000347033. Epub 2013 Feb 26.

Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.

Singapore Med J. 2012 Mar;53(3):164-9.

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Eur Radiol. 2011 Dec;21(12):2527-41. doi: 10.1007/s00330-011-2225-0. Epub 2011 Aug 25.

N-acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling.

Am J Nephrol. 2010;31(2):178-88. doi: 10.1159/000268161. Epub 2009 Dec 17.

Recent advances in Chinese medicine for contrast-induced nephropathy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Recent advances in Chinese medicine for contrast-induced nephropathy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献